Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGoodRx Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | $0.09 | $0.11 | $0.10 |
| Q2 2025 | 4 | $0.10 | $0.11 | $0.10 |
| Q3 2025 | 4 | $0.10 | $0.11 | $0.10 |
| Q4 2025 | 4 | $0.11 | $0.12 | $0.11 |
| Q1 2026 | 3 | $0.11 | $0.12 | $0.11 |
| Q2 2026 | 3 | $0.12 | $0.13 | $0.12 |
| Q3 2026 | 3 | $0.11 | $0.12 | $0.12 |
| Q4 2026 | 3 | $0.12 | $0.13 | $0.12 |
GoodRx Holdings, Inc. Earnings Date And Information
GoodRx Holdings, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by $0.01. The company had revenue of 195.25 M for the quarter and had revenue of 750.27 M for the year. GoodRx Holdings, Inc. has generated $0 earnings per share over the last year ($-0.0216 diluted earnings per share) and currently has a price-to-earnings ratio of -218.94. GoodRx Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
GoodRx Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | $0.09 | $0.03 | -0.06 | $195.66 M | $195.25 M |
| 08/08/2024 | Q2 2024 | $0.09 | $0.02 | -0.07 | $200.47 M | $200.61 M |
| 05/09/2024 | Q1 2024 | -$0.00 | $197.88 M | |||
| 02/29/2024 | Q4 2023 | $0.08 | -$0.06 | -0.14 | $196.64 M | |
| 11/09/2023 | Q3 2023 | $0.06 | -$0.09 | -0.15 | $188.52 M | $179.96 M |
| 08/09/2023 | Q2 2023 | $0.06 | $0.14 | 0.08 | $186.84 M | $189.68 M |
| 05/10/2023 | Q1 2023 | $0.06 | -$0.01 | -0.07 | $183.99 M | |
| 02/28/2023 | Q4 2022 | -$0.00 | $184.11 M | |||
| 11/08/2022 | Q3 2022 | -$0.10 | $185.04 M | $187.32 M | ||
| 08/08/2022 | Q2 2022 | -$0.00 | $184.71 M | $191.80 M | ||
| 05/09/2022 | Q1 2022 | $0.03 | $203.33 M | |||
| 02/28/2022 | Q4 2021 | -$0.10 | $213.26 M | |||
| 11/10/2021 | Q3 2021 | -$0.04 | $194.78 M | $195.10 M | ||
| 08/12/2021 | Q2 2021 | $0.08 | $0.08 | 0 | $174.58 M | $176.64 M |
| 05/13/2021 | Q1 2021 | $0.00 | $160.43 M | |||
| 03/11/2021 | Q4 2020 | -$0.74 | $153.54 M | |||
| 11/12/2020 | Q3 2020 | $0.08 | -$0.21 | -0.29 | $135.07 M | $140.45 M |
| 06/29/2020 | Q2 2020 | $0.07 | $123.30 M | |||
| 03/30/2020 | Q1 2020 | $0.08 | $133.41 M | |||
| 12/30/2019 | Q4 2019 | $0.04 | $113.26 M |
GoodRx Holdings, Inc. Earnings: FAQ's
When is GoodRx Holdings, Inc.'s earnings date?
GoodRx Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
How can I listen to GoodRx Holdings, Inc.'s earnings conference
call?
The conference call for GoodRx Holdings, Inc.'s latest earnings report can be listened to online.
How can I read GoodRx Holdings, Inc.'s conference call transcript?
The conference call transcript for GoodRx Holdings, Inc.'s latest earnings report can be read online.
How much revenue does GoodRx Holdings, Inc. generate each year?
GoodRx Holdings, Inc. (:GDRX) has a recorded annual revenue of $750.27 M.
How much profit does GoodRx Holdings, Inc. generate each year?
GoodRx Holdings, Inc. (:GDRX) has a recorded net income of $750.27 M. GoodRx Holdings, Inc. has generated $-0.0216 earnings per share over the last four quarters.
What is GoodRx Holdings, Inc.'s price-to-earnings ratio?
GoodRx Holdings, Inc. (:GDRX) has a price-to-earnings ratio of -218.94 and price/earnings-to-growth ratio is -2.49.